Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Abingworth raises $315m to expand hunt for promising biotechs

New fund earmarked for early to late-stage European and US firms

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

Blue Latitude Health

- PMLiVE

New ABPI president pledges closer collaboration with NHS

UK pharma body appoints a president and vice president for the first time

- PMLiVE

Daily Brief: Crunch time for Brexit, GSK CEO RSVP from Trump

A round up from pharma, biotech and healthcare

Biogen Idec building

Biogen and Eisai claim mid-stage win for Alzheimer’s drug

Says drug slowed down progression of cognitive decline

- PMLiVE

UDG Healthcare acquires two New-York-based healthcare agencies

Offers a combined total of $82.4m for Create NYC and SmartAnalyst

- PMLiVE

Porterhouse Medical boosts its scientific services team

We are delighted to welcome Loredana Guglielmi to our scientific services team as associate medical writer.Like all of our amazing staff at Porterhouse Medical, Loredana is highly qualified for the role. She...

Porterhouse Medical Group

UK Twitter Hero

The Pharma UK Twitter Ranking 2018 [RESEARCH]

The second edition in our Pharma Social Media Series, the UK Twitter Ranking.

An agency called Owen

Malthus’ orphans

Firms focusing on small, high-profit niches risk falling into a 200-year-old trap

- PMLiVE

Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again

Public row about confidential pricing talks drags on

- PMLiVE

AZ’s Lynparza closes in on first line ovarian cancer use

Aims for first-line indication in the ovarian cancer setting

- PMLiVE

ABPI’s Aileen Thompson is crowned Healthcare Communiquétor 2018

And 90TEN’s Jenny Squibbs wins Young Achiever at this year’s Communiqué Awards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links